Doctor profile · Federal record
Dr. Sunandana Chandra, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Chicago, IL
- NPI 1265696348
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 18 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
645 N. Michigan Avenue, Suite 1006
Chicago, IL 60611
(517) 896-3576 - Mailing address
-
645 N. Michigan Avenue, Suite 1006, Northwestern Medicine Developmental Therapeutics Inst
Chicago, IL 60611
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- May 6, 2014
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New York #262115
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265696348. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
58,659
Distinct HCPCS
10
Medicare allowed
$1,493,422
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9299 |
Injection, nivolumab, 1 mg | 10,080 | 15 | $30 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 9,000 | 12 | $1 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,300 | 29 | $47 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,700 | 29 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,000 | 19 | $54 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,460 | 57 | $44 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,300 | 12 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 2,640 | 22 | $23 | |
J9047 |
Injection, carfilzomib, 1 mg | 1,880 | 15 | $46 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,583 | 17 | $27 |
In context: peer comparison
Among 25 peers in this city , average services per provider: 1,025. This provider delivers 57× the peer median.Open Payments
Industry payments received
All-time total
$17,777
Transactions
23
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 14 | $9,831.66 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $4,927.12 | |
| Merck Sharp & Dohme LLC | 1 | $2,135.00 | |
| ARRAY BIOPHARMA INC | 1 | $730.00 | |
| PFIZER INC. | 1 | $135.00 | |
| Celgene Corporation | 1 | $18.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
44
Patients
0
Total drug cost
$771
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 33 | 0 | $439 |
| Hydrocortisone | Generic | 11 | 0 | $332 |
Hospital affiliations
Frequently asked questions
What is Dr. Sunandana Chandra's medical specialty?
Dr. Sunandana Chandra practices Medical Oncology Physician in Chicago, IL.
Where does Dr. Sunandana Chandra practice?
Dr. Sunandana Chandra practices at 645 N. Michigan Avenue, Chicago, IL 60611. Office phone: 5178963576.
What is Dr. Sunandana Chandra's NPI?
Dr. Sunandana Chandra's National Provider Identifier (NPI) is 1265696348, issued by NPPES.
Does Dr. Sunandana Chandra accept Medicare assignment?
Yes. Dr. Sunandana Chandra accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sunandana Chandra commonly perform?
Top Medicare-reported procedures in 2023: Injection, nivolumab, 1 mg (HCPCS J9299); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.